exendin-4 tirzepatide The peptide “exedin-4” was first isolated from the Venom of the ONLY venomous lizard in the United States. This has helped the medical field develop many “drugs” to help with diabetes. Some Corrination of a GLP-1 Receptor

Green et al., 2006

Appetite Regulation Semaglutide primarily influences the regulation of appetite

thorough metabolic panel (CMP): This is the most important baseline test

It is still being studied in Phase 3 clinical trials and is available only to participants enrolled in approved research studies

For obese individuals with lymphedema, significant weight loss achieved through GLP-1 therapy may offer several advantages: Reduced mechanical load on compromised lymphatic vessels Decreased adipose tissue deposition in affected limbs Improved mobility and exercise tolerance, facilitating physical therapy Reduced systemic inflammation associated with obesity Enhanced quality of life through combined weight loss and symptom improvement Clinical guidelines from organizations such as the National Lymphedema Network and NCCN Survivorship Guidelines emphasize weight management as an important component of comprehensive lymphedema care for overweight patients

Tirzepatide (available through PlexusDx) showed even greater efficacy in SURPASS trials at up to 22.5% weight loss